BACKGROUND: Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥50%) or reduced (HFrEF, EF<50%) ejection fraction (EF), but changes in EF after HF diagnosis are not well described. METHODS AND RESULTS: Among a community cohort of incident HF patients diagnosed from 1984 to 2009 in Olmsted County, Minnesota, we obtained all EFs assessed by echocardiography from initial HF diagnosis until death or last follow-up through March 2010. Mixed effects models fit a unique linear regression line for each person using serial EF data. Compiled results allowed estimates of the change in EF over time in HFpEF and HFrEF. Among 1233 HF patients (48.3% male, mean age 75.0 years, mean follow-up 5.1 years), 559 (45.3%) had HFpEF at diagnosis. In HFpEF, on average, EF decreased by 5.8% over 5 years (P<0.001) with greater declines in older individuals and those with coronary disease. Conversely, EF increased in HFrEF (average increase 6.9% over 5 years, P<0.001). Greater increases were noted in women, younger patients, individuals without coronary disease, and those treated with evidence-based medications. Overall, 39% of HFpEF patients had an EF<50% and 39% of HFrEF patients had an EF≥50% at some point after diagnosis. Decreases in EF over time were associated with reduced survival whereas increases in EF were associated with improved survival. CONCLUSIONS: These data suggest that progressive contractile dysfunction may contribute to the pathophysiology of HFpEF. Prospective longitudinal studies are needed to confirm these observations and establish the mechanism and clinical relevance of decline in EF over time in HFpEF.
BACKGROUND:Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥50%) or reduced (HFrEF, EF<50%) ejection fraction (EF), but changes in EF after HF diagnosis are not well described. METHODS AND RESULTS: Among a community cohort of incident HF patients diagnosed from 1984 to 2009 in Olmsted County, Minnesota, we obtained all EFs assessed by echocardiography from initial HF diagnosis until death or last follow-up through March 2010. Mixed effects models fit a unique linear regression line for each person using serial EF data. Compiled results allowed estimates of the change in EF over time in HFpEF and HFrEF. Among 1233 HF patients (48.3% male, mean age 75.0 years, mean follow-up 5.1 years), 559 (45.3%) had HFpEF at diagnosis. In HFpEF, on average, EF decreased by 5.8% over 5 years (P<0.001) with greater declines in older individuals and those with coronary disease. Conversely, EF increased in HFrEF (average increase 6.9% over 5 years, P<0.001). Greater increases were noted in women, younger patients, individuals without coronary disease, and those treated with evidence-based medications. Overall, 39% of HFpEF patients had an EF<50% and 39% of HFrEF patients had an EF≥50% at some point after diagnosis. Decreases in EF over time were associated with reduced survival whereas increases in EF were associated with improved survival. CONCLUSIONS: These data suggest that progressive contractile dysfunction may contribute to the pathophysiology of HFpEF. Prospective longitudinal studies are needed to confirm these observations and establish the mechanism and clinical relevance of decline in EF over time in HFpEF.
Authors: M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller Journal: Circulation Date: 1981-10 Impact factor: 29.690
Authors: Mark H Drazner; J Eduardo Rame; Emily K Marino; John S Gottdiener; Dalane W Kitzman; Julius M Gardin; Teri A Manolio; Daniel L Dries; David S Siscovick Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094
Authors: M R Bristow; F L Anderson; J D Port; L Skerl; R E Hershberger; P Larrabee; J B O'Connell; D G Renlund; K Volkman; J Murray Journal: Circulation Date: 1991-09 Impact factor: 29.690
Authors: Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren Journal: Lancet Date: 2003-09-06 Impact factor: 79.321
Authors: Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield Journal: Circulation Date: 2014-11-12 Impact factor: 29.690
Authors: Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Sheila M Manemann; Alanna M Chamberlain; Ruoxiang Jiang; Véronique L Roger Journal: JAMA Cardiol Date: 2016-05-01 Impact factor: 14.676
Authors: Yariv Gerber; Susan A Weston; Cecilia Berardi; Sheila M McNallan; Ruoxiang Jiang; Margaret M Redfield; Véronique L Roger Journal: Am J Epidemiol Date: 2013-08-29 Impact factor: 4.897
Authors: Christina L Clarke; Gary K Grunwald; Larry A Allen; Anna E Barón; Pamela N Peterson; David W Brand; David J Magid; Frederick A Masoudi Journal: Circ Cardiovasc Qual Outcomes Date: 2013-10-15
Authors: Andrew H Coles; Kimberly Fisher; Chad Darling; Jorge Yarzebski; David D McManus; Joel M Gore; Darleen Lessard; Robert J Goldberg Journal: Am J Cardiol Date: 2014-07-02 Impact factor: 2.778